Innocan Pharma to Present Innovative Cannabidiol Research
Innocan Pharma Showcases Cannabidiol Research at PAINWeek 2025
Innocan Pharma Corporation, a leader in the pharmaceutical and biotechnology sectors, is set to showcase groundbreaking research during the upcoming PAINWeek conference. Their poster presentation titled "Is Long-Acting Synthetic Cannabidiol a Solution to Chronic Pain?" will highlight the company’s commitment to advancing pain management solutions.
Understanding PAINWeek
PAINWeek is renowned as the leading conference in the United States focused on pain management. It's an opportunity for clinicians, researchers, and educators to come together and share insights on cutting-edge practices and innovative research. This year’s event offers a unique platform for Innocan to present their findings to industry professionals eager for advancements in non-opioid pain management.
The Poster Presentation
The presentation will outline key data on the pharmacokinetics and efficacy of Innocan's Long-Acting Synthetic Cannabidiol, known as LPT-CBD. Accompanying the presentation will be the newly published narrative review titled "Considering Long-Acting Synthetic Cannabidiol for Chronic Pain: A Narrative Review," which provides extensive insights into the potential of synthetic cannabidiol as a non-opioid analgesic.
Innocan's Innovative Developments
Focusing on LPT-CBD, Innocan is developing an innovative injectable liposomal drug product meant for the sustained release of synthetic CBD. Through extensive preclinical animal studies, LPT-CBD has shown remarkable outcomes, including steady plasma levels of CBD lasting up to four weeks and prolonged pain relief with excellent tolerability. This offers a promising non-opioid alternative which addresses the critical need for solutions that help mitigate opioid dependency.
Importance of the Endocannabinoid System
The endocannabinoid system is increasingly recognized as a valid target for pain modulation. Innocan's LPT-CBD platform could represent a breakthrough in the treatment of chronic pain, potentially offering a safe and effective non-opioid therapy at a time when the opioid crisis continues to impact patient care.
Meeting the Demand for Non-Opioid Therapies
As Innocan prepares to present their findings at PAINWeek, they are not just showing data; they're providing hope to healthcare professionals and patients seeking better pain management options. Presenting to thousands of attendees, this event will position their innovative research and development efforts at the forefront of non-opioid chronic pain solutions.
“We are honored to be included among the esteemed voices presenting at PAINWeek this year,” expressed Iris Bincovich, CEO of Innocan. “This recognition underscores our commitment to advancing evidence-based pain care and contributing meaningful research to the field,” she added.
About Innocan Pharma
Innocan is prioritizing innovation within both pharmaceuticals and wellness sectors. Their pharmaceutical development includes a CBD-loaded liposome drug delivery platform designed for accurate dosing and controlled release for effective pain management. In the wellness arena, Innocan offers a range of self-care and beauty products aimed at promoting healthier lifestyles, operating through their subsidiary, BI Sky Global Ltd., which facilitates advanced online sales.
Contact Information
For more information or to arrange a meeting with Innocan during PAINWeek, please contact:
Iris Bincovich, CEO
Phone: +1 5162104025
Mobile: +972-54-3012842
Email: info@innocanpharma.com
Frequently Asked Questions
What is Innocan Pharma showcasing at PAINWeek 2025?
Innocan Pharma is presenting groundbreaking research on their Long-Acting Synthetic Cannabidiol, LPT-CBD, and its potential for chronic pain relief.
When is PAINWeek 2025?
PAINWeek 2025 will take place from September 2 to 5, 2025, in Las Vegas.
What is the significance of LPT-CBD?
LPT-CBD is designed for sustained release of synthetic CBD, providing a promising alternative to opioids in pain management.
How can I arrange a meeting with Innocan at PAINWeek?
You can arrange a meeting by emailing info@innocanpharma.com.
Where can I find more information about Innocan Pharma?
For additional details about Innocan Pharma, visit their official website at www.innocanpharma.com.
About The Author
Contact Riley Hayes privately here. Or send an email with ATTN: Riley Hayes as the subject to contact@investorshangout.com.
About Investors Hangout
Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/
The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.
